Cargando…
Migrastatics—Anti-metastatic and Anti-invasion Drugs: Promises and Challenges
In solid cancers, invasion and metastasis account for more than 90% of mortality. However, in the current armory of anticancer therapies, a specific category of anti-invasion and antimetastatic drugs is missing. Here, we coin the term ‘migrastatics’ for drugs interfering with all modes of cancer cel...
Autores principales: | Gandalovičová, Aneta, Rosel, Daniel, Fernandes, Michael, Veselý, Pavel, Heneberg, Petr, Čermák, Vladimír, Petruželka, Luboš, Kumar, Sunil, Sanz-Moreno, Victoria, Brábek, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482322/ https://www.ncbi.nlm.nih.gov/pubmed/28670628 http://dx.doi.org/10.1016/j.trecan.2017.04.008 |
Ejemplares similares
-
Are We Ready for Migrastatics?
por: Solomon, Jonathan, et al.
Publicado: (2021) -
High-throughput transcriptomic and proteomic profiling of mesenchymal-amoeboid transition in 3D collagen
por: Čermák, Vladimír, et al.
Publicado: (2020) -
Sustained Inflammatory Signalling through Stat1/Stat2/IRF9 Is Associated with Amoeboid Phenotype of Melanoma Cells
por: Gandalovičová, Aneta, et al.
Publicado: (2020) -
Primary assessment of medicines for expected migrastatic potential with holographic incoherent quantitative phase imaging
por: Šuráňová, Markéta, et al.
Publicado: (2023) -
Quantitative phase imaging unravels new insight into dynamics of mesenchymal and amoeboid cancer cell invasion
por: Tolde, Ondřej, et al.
Publicado: (2018)